Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 81
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04865458 | A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies | ||
| NCT03943251 | The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects | ||
| NCT04625361 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects | ||
| NCT03502902 | The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects | ||
| NCT05139719 | A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients | ||
| NCT05127772 | A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing | ||
| NCT03662568 | A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects | ||
| NCT03673696 | The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects | ||
| NCT07082842 | Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF | ||
| NCT05059743 | ADME Study of [14C]- Larotinib in Healthy Male Subjects | ||
| NCT04232514 | Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects | ||
| NCT03663686 | The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects | ||
| NCT04422496 | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects | ||
| NCT03092102 | The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects | ||
| NCT04194242 | The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects | ||
| NCT05048368 | Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function | ||
| NCT04827069 | A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML) | ||
| NCT07341672 | A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants | ||
| NCT05383131 | To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers | ||
| NCT07588646 | Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects | ||
| NCT04546984 | Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects | ||
| NCT05504876 | Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114 | ||
| NCT05060822 | Phase ll Study of HEC585 in Patients With IPF | ||
| NCT05459285 | A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects | ||
| NCT04147208 | Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection | ||
| NCT04324372 | Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors | ||
| NCT04925661 | HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia | ||
| NCT04131192 | Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer | ||
| NCT07102251 | A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects | ||
| NCT03655873 | The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects | ||
| NCT03876925 | A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC | ||
| NCT03886688 | HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers | ||
| NCT07376200 | Single-ascending Dose Study of HEC-151 Injection | ||
| NCT04565171 | Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD | ||
| NCT05374343 | A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment | ||
| NCT05446233 | ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects | ||
| NCT05497674 | Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects | ||
| NCT05468346 | Study on the Body Mass Balance and Biotransformation of [14C]-HEC585 | ||
| NCT05802862 | A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China | ||
| NCT04601610 | KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma | ||
| NCT05397379 | A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis | ||
| NCT05492630 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects | ||
| NCT05294536 | A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects | ||
| NCT04202952 | The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects | ||
| NCT03811678 | The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects | ||
| NCT07211165 | Clinical Study on the Mass Balance of Clifutinib | ||
| NCT04667429 | the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets | ||
| NCT04992858 | Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations | ||
| NCT04623814 | the Safety, Tolerability, and Pharmacokinetics Study of HEC113995 | ||
| NCT03758287 | Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative |
